Friday, November 1 |
|
7:50 am - 8:00 am |
Welcome - Opening Remarks |
Session I |
|
8:00 am – 8:45 am |
THE DATA: The Rationale for Brachytherapy for the Treatment of Prostate Cancer
|
Session II |
|
8:45 am - 11:30 am |
PRACTICAL LDR AND HDR BRACHYTHERAPY
|
Session III |
|
11:30 am – 12:00 pm |
A Successful Brachytherapy Practice
|
12:00 pm – 1:00 pm |
Lunch with Lecture: “Lessons I’ve Learned” |
Session IV |
|
1:00 pm – 1:45 pm |
Review of Treatment Planning Solutions: The Technology and Tools for a Successful Brachytherapy Practice |
2:00 pm – 2:30 pm |
Keynote Address: Disruptive Technologies in Prostate Cancer: The Use of Genomic Markers and Prostate Biopsy Decisions |
2:30 pm - 5:30 pm |
Hands-on Workshops |
6:30 pm |
Reception |
Saturday, November 2 |
|
7:45 am – 8 am |
Safety: NRC 101 |
8:00 am – 11:30 pm |
Hands-on Workshop |
11:30 am – 12:30pm |
Lunch |
1:00 pm – 4:00 pm |
Hands-on Workshop |
4:00 PM |
Closing remarks |
Station 1: LDR Pre-loaded Stranded
Mira Keyes, MD
Brian J. Moran, MD
Station 2: LDR Mick
Brett W. Cox, MD
Marissa A. Kollmeier, MD
Louis Potters, MD
Abhirup Sakar, PhD
Station 3: LDR Real Time
Dan Cail, PhD
Martin King, MD
Peter F. Orio, III, DO, MS
Station 4: Fiducial Markers & Spacing Solutions
Sushil Beriwal, MD, MBA
Brian J. Davis, MD
Steven J. Frank, MD
Tyler Robin, MD, PhD
Station 5: HDR Elekta US
Matt Giles, MSc
Alvaro Martinez, MD
Gerard C. Morton, MD, FABS
Station 6: HDR Elekta CT/MRI
Daniel J. Krauss, MD
Mahta M. McKee, MS
Firas Mourtada, PhD
Peter J. Rossi, MD
Station 7: HDR Varian US
Christopher Deufel, PhD
Bradley R. Prestidge, MD, MS, FABS
Station 8: HDR Varian CT
Bruce Libby, PhD
Timothy N. Showalter, MD
Station 9: Industry Showcase
Arsalan Siddique, MD
Peter J. Rossi, MD